BMY |
Bristol-Myers Squibb Company |
124.10B |
8.87% |
|
|
|
|
|
60.99 |
1.62% |
37.28% |
102.79% |
---|
PFE |
Pfizer Inc. |
143.71B |
7.20% |
|
|
|
|
|
25.34 |
0.52% |
34.62% |
89.90% |
---|
ABBV |
AbbVie Inc. |
370.64B |
7.09% |
|
|
|
|
|
209.52 |
2.06% |
29.95% |
83.23% |
---|
JNJ |
Johnson & Johnson |
399.65B |
6.83% |
|
|
|
|
|
165.84 |
1.30% |
21.99% |
62.50% |
---|
MRK |
Merck & Co., Inc. |
226.74B |
6.56% |
|
|
|
|
|
89.76 |
0.59% |
37.73% |
98.40% |
---|
GILD |
Gilead Sciences, Inc. |
139.54B |
4.60% |
|
|
|
|
|
112.05 |
0.23% |
31.47% |
62.97% |
---|
CAH |
Cardinal Health, Inc. |
33.28B |
4.13% |
|
|
|
|
|
137.77 |
0.97% |
30.61% |
55.03% |
---|
VTRS |
Viatris Inc. |
10.40B |
4.05% |
|
|
|
|
|
8.71 |
0.35% |
30.87% |
89.83% |
---|
UTHR |
United Therapeutics Corporation |
13.85B |
3.75% |
|
|
|
|
|
308.27 |
0.42% |
35.09% |
80.77% |
---|
JAZZ |
Jazz Pharmaceuticals plc |
7.54B |
3.56% |
|
|
|
|
|
124.15 |
1.00% |
31.17% |
58.21% |
---|
ZTS |
Zoetis Inc. |
73.73B |
3.49% |
|
|
|
|
|
164.65 |
0.94% |
29.70% |
38.21% |
---|
LLY |
Eli Lilly and Company |
782.95B |
3.19% |
|
|
|
|
|
825.91 |
0.41% |
50.88% |
78.39% |
---|
AMGN |
Amgen Inc. |
167.37B |
3.07% |
|
|
|
|
|
311.55 |
1.50% |
32.93% |
38.30% |
---|
BIIB |
Biogen Inc. |
20.03B |
2.90% |
|
|
|
|
|
136.84 |
-1.11% |
41.63% |
62.19% |
---|
OGN |
Organon & Co. |
3.84B |
2.42% |
|
|
|
|
|
14.89 |
2.62% |
45.12% |
72.27% |
---|
CRL |
Charles River Laboratories International... |
7.70B |
2.40% |
|
|
|
|
|
150.52 |
-3.23% |
44.67% |
70.37% |
---|
REGN |
Regeneron Pharmaceuticals, Inc. |
68.18B |
2.34% |
|
|
|
|
|
634.23 |
-0.49% |
41.65% |
83.38% |
---|
MEDP |
Medpace Holdings, Inc. |
9.28B |
1.86% |
|
|
|
|
|
304.69 |
-2.46% |
56.20% |
45.75% |
---|
NBIX |
Neurocrine Biosciences, Inc. |
11.03B |
1.61% |
|
|
|
|
|
110.60 |
-2.26% |
34.71% |
33.35% |
---|
ELAN |
Elanco Animal Health Incorporated |
5.19B |
1.60% |
|
|
|
|
|
10.50 |
0.86% |
53.28% |
36.35% |
---|
ALKS |
Alkermes plc |
5.37B |
1.13% |
|
|
|
|
|
33.02 |
-0.57% |
55.46% |
64.86% |
---|
EXEL |
Exelixis, Inc. |
10.33B |
1.12% |
|
|
|
|
|
36.92 |
0.60% |
35.76% |
38.77% |
---|
HALO |
Halozyme Therapeutics, Inc. |
7.88B |
1.10% |
|
|
|
|
|
63.81 |
-0.05% |
37.56% |
28.92% |
---|
PBH |
Prestige Consumer Healthcare Inc. |
4.26B |
0.95% |
|
|
|
|
|
85.97 |
1.03% |
28.23% |
53.02% |
---|
PRGO |
Perrigo Company plc |
3.83B |
0.95% |
|
|
|
|
|
28.04 |
-0.07% |
43.05% |
45.85% |
---|
CORT |
Corcept Therapeutics Incorporated |
12.05B |
0.79% |
|
|
|
|
|
114.22 |
109.08% |
65.42% |
42.79% |
---|
TGTX |
TG Therapeutics, Inc. |
6.19B |
0.74% |
|
|
|
|
|
39.43 |
-1.08% |
53.62% |
34.42% |
---|
PTGX |
Protagonist Therapeutics, Inc. |
2.97B |
0.69% |
|
|
|
|
|
48.36 |
-1.06% |
68.70% |
-0.14% |
---|
ACLX |
Arcellx, Inc. |
3.60B |
0.63% |
|
|
|
|
|
65.60 |
-3.47% |
46.12% |
21.94% |
---|
ITCI |
Intra-Cellular Therapies, Inc. |
14.05B |
0.63% |
|
|
|
|
|
131.92 |
0.08% |
11.93% |
0.66% |
---|
ALNY |
Alnylam Pharmaceuticals, Inc. |
35.12B |
0.62% |
|
|
|
|
|
270.02 |
0.58% |
41.52% |
27.67% |
---|
TWST |
Twist Bioscience Corporation |
2.34B |
0.60% |
|
|
|
|
|
39.26 |
-2.73% |
66.71% |
59.64% |
---|
VCEL |
Vericel Corporation |
2.24B |
0.59% |
|
|
|
|
|
44.62 |
0.27% |
58.27% |
94.35% |
---|
INCY |
Incyte Corporation |
11.72B |
0.57% |
|
|
|
|
|
60.55 |
-0.08% |
42.37% |
46.19% |
---|
ADMA |
ADMA Biologics, Inc. |
4.71B |
0.55% |
|
|
|
|
|
19.84 |
-2.07% |
61.47% |
22.84% |
---|
ACAD |
ACADIA Pharmaceuticals Inc. |
2.77B |
0.55% |
|
|
|
|
|
16.61 |
-2.69% |
52.38% |
68.59% |
---|
ROIV |
Roivant Sciences Ltd. |
7.20B |
0.51% |
|
|
|
|
|
10.09 |
-2.79% |
32.36% |
65.09% |
---|
EXAS |
Exact Sciences Corporation |
8.04B |
0.50% |
|
|
|
|
|
43.29 |
-0.85% |
63.70% |
41.07% |
---|
BPMC |
Blueprint Medicines Corporation |
5.66B |
0.50% |
|
|
|
|
|
88.51 |
-0.24% |
66.68% |
51.48% |
---|
AMRX |
Amneal Pharmaceuticals, Inc. |
3.90B |
0.50% |
|
|
|
|
|
8.38 |
1.21% |
67.35% |
35.90% |
---|
INSM |
Insmed Incorporated |
13.81B |
0.49% |
|
|
|
|
|
76.29 |
-2.18% |
46.27% |
6.76% |
---|
SRPT |
Sarepta Therapeutics, Inc. |
6.19B |
0.49% |
|
|
|
|
|
63.82 |
-9.36% |
62.25% |
28.47% |
---|
KRYS |
Krystal Biotech, Inc. |
5.19B |
0.45% |
|
|
|
|
|
180.30 |
-1.97% |
46.99% |
44.75% |
---|
KYMR |
Kymera Therapeutics, Inc. |
1.78B |
0.45% |
|
|
|
|
|
27.37 |
-7.60% |
67.60% |
76.87% |
---|
BMRN |
BioMarin Pharmaceutical Inc. |
13.49B |
0.44% |
|
|
|
|
|
70.69 |
-1.05% |
33.04% |
31.80% |
---|
VRTX |
Vertex Pharmaceuticals Incorporated |
124.50B |
0.44% |
|
|
|
|
|
484.82 |
-1.60% |
28.94% |
30.37% |
---|
IONS |
Ionis Pharmaceuticals, Inc. |
4.80B |
0.40% |
|
|
|
|
|
30.17 |
-3.15% |
57.02% |
66.99% |
---|
RNA |
Avidity Biosciences, Inc. |
3.55B |
0.36% |
|
|
|
|
|
29.52 |
-6.58% |
67.15% |
33.14% |
---|
VKTX |
Viking Therapeutics, Inc. |
2.71B |
0.34% |
|
|
|
|
|
24.15 |
-5.85% |
78.17% |
50.97% |
---|
MYGN |
Myriad Genetics, Inc. |
809.91M |
0.26% |
|
|
|
|
|
8.87 |
-0.11% |
60.35% |
76.22% |
---|
|
US Dollar |
|
0.13% |
|
|
|
|
|
|
|
|
|
---|